The Ethical Challenges of Human Research by Miller, Franklin G.;

Selected Essays

GET 10% OFF
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.

Publisher's listprice GBP 77.00
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.

36 786 Ft (35 035 Ft + 5% VAT)
Discount 10% (cc. 3 679 Ft off)
Discounted price 33 108 Ft (31 532 Ft + 5% VAT)

36 786 Ft

Availability

printed on demand

Product details:

Publisher OUP USA
Date of Publication 15 November 2012

ISBN 9780199896202
Binding Hardback
No. of pages352 pages
Size 236x160x33 mm
Weight 567 g
Language English

Short description:

This book contains 22 essays on the ethics of research involving human subjects written over a 15-year period. Topics addressed include the ethics of clinical trials, controversial study designs, and informed consent.

Long description:

The use of human beings as research subjects poses distinctive ethical issues. Subjects of medical research are exposed to risks of harm for the sake of generating scientific knowledge that can benefit future patients and society. Ethical analysis of the challenges posed by research involving human subjects requires careful attention to the contextual details of scientific experimentation. This book contains 22 essays by Franklin G. Miller on research ethics written over a 15-year period. With the exception of the first essay, all have been previously published in bioethics and medical journals.
The book is arranged into four parts. Part One addresses a general ethical perspective on the protection of human subjects in clinical research, including paternalism in research regulation and acceptable limits to research risks. The essays in Part Two examine ethical issues in study design. It includes ethical analyses of controversial types of medical experimentation-studies that provoke psychiatric symptoms, induce infections, provide patients with placebos that withhold proven effective treatments or administer fake invasive procedures, test experimental treatments in cancer patients who have exhausted all standard treatment options, and employ the use of deception to generate scientifically valid data. Part Three offers a systematic critique of "the therapeutic orientation" to clinical trials and the principle of clinical equipoise, which is widely regarded as a fundamental norm for randomized treatment studies. Part Four takes up a range of ethical issues relating to informed consent for research participation, including examination of "the therapeutic misconception" and presentation of a novel approach to the validity of consent: "the fair transaction model." An abiding theme, developed in many of the essays is that the ethics of clinical research is importantly different from the ethics of medical care.

Preface
Acknowledgments
Part One: Protecting Human Subjects in Clinical Research: A General Perspective
1. Miller FG. Situating research ethics: revisiting Beecher and Jonas
2. Miller FG, Wertheimer A. Facing up to paternalism in research ethics. Hastings Center Report 2007;37(3):24-34.
3. Miller FG, Joffe S. Limits to research risks. Journal of Medical Ethics 2009;35:445-449.
Part Two: Study Design
4. Miller FG, Rosenstein DL. Psychiatric symptom-provoking studies: an ethical appraisal. Biological Psychiatry. 1997;42:403-9.
5. Miller FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clinical Infectious Diseases. 2001;33:1028-33.
6. Miller FG. Placebo-controlled trials in psychiatric research: an ethical perspective. Biological Psychiatry. 2000;47:707-16.
7. Miller FG, Brody H. What makes placebo-controlled trials unethical? The American Journal of Bioethics. 2002;2(2):3-9.
8. Miller FG, Emanuel EJ, Rosenstein DL, Straus SE. Ethical issues concerning research on complementary and alternative medicine. JAMA 2004;291:599-604.
9. Miller FG. Sham surgery: an ethical analysis. American Journal of Bioethics 2003;3(4):41-8;
10. Miller FG, Joffe S. Benefit in phase 1 oncology trials: therapeutic misconception or reasonable treatment option? Clinical Trials 2008;5:617-23.
11. Miller FG, Wendler D, Swartzman L. Deception in research on the placebo effect. PLoS Medicine 2005;2(9):e262.
12. Miller FG, Gluck JP, Wendler D. Debriefing and accountability in deceptive research. Kennedy Institute of Ethics Journal 2008;18:235-51.
Part Three: Therapeutic Orientation and Equipoise
13. Miller FG, Rosenstein DL, DeRenzo EG. Professional integrity in clinical research. Journal of the American Medical Association. 1998;280:1449-54.
14. Miller FG, Rosenstein DL. The therapeutic orientation to clinical trials. New England Journal of Medicine. 2003;348:1383-86.
15. Miller FG, Brody H. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. Hastings Center Report. 2003;33(3):19-28.
16. Miller FG, Brody H. Clinical equipoise and the incoherence of research ethics. Journal
of Medicine and Philosophy 2007;32:151-65.
17. Miller FG, Joffe S. Equipoise and the randomized clinical trial dilemma. New England Journal of Medicine 2011;364:476-80.
Part Four: Consent
18. Miller FG, Joffe S. Evaluating the therapeutic misconception. Kennedy Institute of Ethics Journal 2006;16:353-66.
19. Miller FG, Wendler D. Is it ethical to keep interim findings of randomized controlled trials confidential? Journal of Medical Ethics 2008;34:198-201.
20. Miller FG. Research on medical records without informed consent, Journal of Law, Medicine & Ethics 2008;36:560-66.
21. Miller FG, Pearson SD. Coverage with evidence development: ethical issues and policy implications. Medical Care 2008;46:746-57.
22. Miller FG, Wertheimer A. The fair transaction model of informed consent: an alternative to autonomous authorization, Kennedy Institute of Ethics Journal 2011;21:201-18.